Anxiolytic effect of BPC-157, a gastric pentadecapeptide: Shock probe/burying test and light/dark test

Acta Pharmacologica Sinica

Volumn 22, Issue 3, 2001, Pages 225-230

  Sikiric, P ^a   Jelovac, N ^a   Jelovac Gjeldum, A ^a   Dodig, G ^a   Staresinic, M ^a   Anic, T ^a   Zoricic, I ^a   Perovic, D ^a   Aralica, G ^a   Buljat, G ^a   Prkacin, I ^a   Lovric Bencic, M ^a   Separovic, J ^a   Seiwerth, S ^a   Rucman, R ^a   Petek, M ^a   Turkovic, B ^a   Ziger, T ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Anxiety; BPC 157; Diazepam; Exploratory behavior; Motor activity

Indexed keywords

DIAZEPAM; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALAN YLGLYCYLLEUCYLVALINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; PENTAPEPTIDE; UNCLASSIFIED DRUG; ANTI ANXIETY AGENTS, BENZODIAZEPINE; ANXIOLYTIC AGENT; PEPTIDE FRAGMENT; PROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DARKNESS; DRUG EFFECT; ELECTRIC SHOCK; EXPLORATORY BEHAVIOR; MALE; NONHUMAN; PHOTOREACTIVITY; ANIMAL; ANXIETY; COMPARATIVE STUDY; LIGHT; MOUSE; RANDOMIZATION; RAT; RAT STRAIN;

ANIMAL; ANTI-ANXIETY AGENTS; ANTI-ANXIETY AGENTS, BENZODIAZEPINE; ANXIETY; BEHAVIOR, ANIMAL; COMPARATIVE STUDY; DARKNESS; DIAZEPAM; LIGHT; MALE; MICE; PEPTIDE FRAGMENTS; PROTEINS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 0035106955     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. The pharmacological properties of the novel peptide BPC-157 (PL-10)
2. 2 receptor antagonists, dopamine promotors and gut peptides
3. New model of cytoprotection/adaptive cytoprotection in rats: Endogenous small irritants, antiulcer agents and indomethacin
4. The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury
5. The protective effect of newly isolated peptide PL-10 in the iodoacetamide colitis in rats
6. BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats
7. The effect of new gastric juice peptide BPC on classic stress triad in stress procedure
8. Pentadecapeptide BPC-157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress
9. G-nitro-L-arginine methylester and L-arginine effect on stomach mucosal integrity and blood pressure
10. The beneficial effect of a novel pentadecapeptiide BPC-157 on gastric lesions induced by restraint stress, ethanol, indomethacin and capsaicin neurotoxicity
11. Pentadecapeptide BPC-157 beneficially influences the healing of colon-colon anastomoses in rats
12. Osteogenic effect of a gastric pentadecapeptide BPC-157, on the healing of segmental bone defect in rabbits. A comparison with bone marrow and autologous cortical bone implantation
13. Effects of BPC-157 on the healing of corneal lesions
14. Pentadecapeptide BPC-157 positively affects both non-steroidal anti-inflammatory agents-induced gastrointestinal lesions and adjuvant arthritis in rats
15. A novel pentadecapeptide, BPC-157, blocks the stereotypy produced acutely by amphetamine and the development of haloeprdol-induced supersensitivity to amphetamine
16. Pentadecapeptide BPC-157 attenuates disturbances induced by neuroleptics: The effect on catalepsy and gastric ulcers
17. A behavioural study of the effect of pentadecapeptide BPC-157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
18. The effect of a novel pentadecapeptide BPC-157 on development of tolerance and physical dependence following repeated administration of diazepam
19. The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants
20. Digestion of h-EGF, h-TGF alpha, and BPC-15 in human gastric juice
21. The enhancement of hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitiviy in mice
22. Aminobutyric acid (GABA) receptor stimulation.I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticovulsant spectra
23. A comparison of anxiolytic and non-anxiolytic agents in the shock-probe/burying test for anxiolytics
24. Noninteractive effects of diazepam and amygdaloid lesions in two animal models of anxiety
25. Effects of traumatic stress on defensive burying: An alternative test of the learned helplessness animal model of depression and enhanced retrieval of unpleasant memories
26. The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam
27. Exploration of mice in black and white test box: Validation as a model of anxiety
28. Comparison of mutes of administration and time course effects of zacopride and buspirone in mice using an automated light/dark test
29. 3 receptor antagonists and anxiety; a preclinical and clinical review
30. Behavioral effects of flibanserin (BIMT 17)
31. Behavioral and neurochemical alterations evoked by p-chlorophenylalanine application in rots examined in the light-dark crossing test
32. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety
33. 3 antagonist, in a light/dark test in mice
34. 2 receptor antagonist, in rodent and primate models of anxiety
35. Administration of cholecystokinin sulphated octapeptide (CCK-8S) induces changes on rat amino acid tissue levels and on a behavioral test for anxiety
36. 4 receptor antagonists to modify chug induced disinhibitory effects in the mouse light/dark test
37. Characterization of serotonergic mechanisms involved in the behavioural inhibition induced by 5-hydroxytryptophan in a modified light-dark test in mice
38. Experimental anxiety and antidepressant drugs: The effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice
39. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001